MentionFox
Home › funding signals › MindImmune Therapeutics, Inc.
Company · SEC filings

MindImmune Therapeutics, Inc. funding history

MindImmune Therapeutics, Inc. has 2 Form D filings on record, from 2025-12-05 to 2026-03-05. Together its new offerings report $10.20M sold.

Funding historyFounders and team

What do you want to do with MindImmune Therapeutics, Inc.?

Based
KINGSTON, RHODE ISLAND
Industry group
Pharmaceuticals
Filings
2
Raised (new offerings)
$10.20M

Every filing

FiledTypeAmount soldTotal offeringRecords
2026-03-05Amendment
first sale 2025-11-24
$15.22M$17.01MSEC filing
2025-12-05New offering
first sale 2025-11-24
$10.20M$12MSEC filing

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from MindImmune Therapeutics, Inc.'s own filings with the SEC. The people those filings name are on the team page.

Cite this page

Permanent URL: https://mentionfox.com/company/mindimmune-therapeutics-inc
Last updated 2026-09-26
Primary record: SEC filing 1 · SEC filing 2
MindImmune Therapeutics, Inc. funding history: 2 SEC filings, $10.20M raised. MentionFox, 2026-09-26. https://mentionfox.com/company/mindimmune-therapeutics-inc